Feline Asthma: Diagnosis and Management

At a Glance

Feline asthma is a chronic lower airway disease characterized by eosinophilic airway inflammation, bronchoconstriction, and airway remodeling. Diagnosis requires integration of history, physical examination findings, thoracic radiography, and advanced diagnostics such as bronchoscopy with bronchoalveolar lavage. Management centers on reducing airway inflammation with corticosteroids, relieving bronchoconstriction with bronchodilators, and minimizing environmental triggers. The table below summarizes the key diagnostic and management components.

Pathophysiology of Feline Asthma

Feline asthma is an allergic respiratory disease driven by a type I hypersensitivity reaction to inhaled allergens. The immune response leads to eosinophilic infiltration of the bronchial mucosa, mucus hypersecretion, smooth muscle hypertrophy, and airway remodeling. These changes result in reversible and irreversible airway obstruction. The condition is distinct from chronic bronchitis, which is characterized by neutrophilic inflammation and is less responsive to corticosteroid therapy. Understanding this pathophysiology guides diagnostic and therapeutic decisions. The Merck Veterinary Manual provides an overview of feline respiratory disorders (Merck Veterinary Manual, https://www.merckvetmanual.com/). The World Organisation for Animal Health addresses animal health and welfare standards relevant to chronic disease management (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare).

Diagnostic Workup

History and Physical Examination

Obtain a thorough history focusing on cough frequency, character, and triggers. Owners often describe a dry, hacking cough that may be mistaken for hairball attempts. Note any episodes of acute dyspnea, open-mouth breathing, or wheezing. Identify potential environmental triggers such as cigarette smoke, aerosolized cleaners, dusty cat litter, or perfumes. Physical examination may reveal increased respiratory effort, expiratory wheezes, and a prolonged expiratory phase. Auscultation can detect crackles or wheezes, but some cats with asthma have normal lung sounds. The presence of a cough in a cat with no other clinical signs should raise suspicion for feline asthma. The American College of Veterinary Internal Medicine provides resources on respiratory disease diagnosis (American College of Veterinary Internal Medicine, https://www.acvim.org/).

Thoracic Radiography

Thoracic radiography is a cornerstone of the diagnostic workup. Obtain three-view radiographs (right lateral, left lateral, and ventrodorsal or dorsoventral) to evaluate the pulmonary parenchyma and airways. Classic findings include a bronchial pattern characterized by thickened, prominent bronchial walls (doughnut or tramline signs). Lung hyperinflation due to air trapping is common, and the right middle lung lobe may appear collapsed or consolidated. However, radiographs can be normal in cats with mild or early disease. Radiography also helps rule out other causes of respiratory signs such as pneumonia, neoplasia, heartworm disease, or pleural effusion. The Merck Veterinary Manual includes guidance on thoracic radiography interpretation (Merck Veterinary Manual, https://www.merckvetmanual.com/). A study on tomographic evaluation of bronchial and pulmonary vascular relationships in cats infected with immature Dirofilaria immitis highlights the importance of advanced imaging in differentiating asthma from other conditions (Tomographic Evaluation of the Bronchial and Pulmonary Vascular Relationships in Cats Naturally Infected with Immature Dirofilaria immitis, https://doi.org/10.3390/ani15223320).

Bronchoscopy and Bronchoalveolar Lavage

Bronchoscopy allows direct visualization of the trachea and bronchi. In asthmatic cats, the airway mucosa may appear erythematous, edematous, or hyperemic. Excessive mucus or bronchial narrowing may be observed. Bronchoalveolar lavage (BAL) is performed during bronchoscopy to collect samples for cytology and culture. A BAL fluid differential cell count showing greater than 20% eosinophils is highly suggestive of feline asthma. Neutrophilic inflammation suggests chronic bronchitis or infection. BAL also helps rule out bacterial, fungal, or parasitic infections. The procedure requires general anesthesia and should be performed by a veterinarian experienced in respiratory endoscopy. The International Society of Feline Medicine provides guidelines on feline respiratory disease management (International Society of Feline Medicine, https://catvets.com/guidelines). A review of feline asthma diagnosis and treatment emphasizes the role of BAL in confirming the diagnosis (Feline Asthma: Diagnostic and Treatment Update, https://pubmed.ncbi.nlm.nih.gov/31812220).

Additional Diagnostic Tests

Complete blood count and serum biochemistry are generally unremarkable in feline asthma but help rule out systemic disease. Fecal examination for lungworm larvae (e.g., Aelurostrongylus abstrusus) is indicated in cats with outdoor access or a history of hunting. Heartworm testing (antigen and antibody) is recommended because heartworm-associated respiratory disease can mimic asthma. A study on clinical and histopathological investigation of tracheobronchial disease in cats with chronic gingivostomatitis suggests a possible link between oral inflammation and lower airway disease, warranting further investigation in cats with concurrent oral pathology (Clinical and histopathological investigation of the possible occurrence of tracheobronchial disease in cats with chronic gingivostomatitis, https://doi.org/10.3389/fvets.2025.1624016).

Medical Management

Corticosteroid Therapy

Corticosteroids are the mainstay of anti-inflammatory therapy for feline asthma. They reduce eosinophilic inflammation, decrease mucus production, and improve airway function. Options include oral prednisolone, injectable corticosteroids, and inhaled corticosteroids delivered via a metered-dose inhaler with a spacer device. Oral prednisolone is effective for initial control and acute exacerbations. Inhaled corticosteroids such as fluticasone propionate are preferred for long-term management because they minimize systemic side effects. The choice between oral and inhaled therapy depends on the cat's temperament, owner compliance, and disease severity. A review of feline asthma treatment recommendations discusses the advantages and disadvantages of each route (Feline Asthma-Update on Diagnosis and Treatment Recommendations, https://pubmed.ncbi.nlm.nih.gov/42320919). An overview of diagnostics and therapy for feline asthma and chronic bronchitis provides additional context on corticosteroid use ([Feline asthma and chronic bronchitis - an overview of diagnostics and therapy], https://pubmed.ncbi.nlm.nih.gov/31212350).

Bronchodilator Therapy

Bronchodilators provide rapid relief of bronchoconstriction and are used as rescue therapy during acute asthma attacks. Inhaled beta-2 agonists such as albuterol are the preferred bronchodilators. They can be administered via a metered-dose inhaler with a spacer and face mask. Oral bronchodilators such as terbutaline are less commonly used due to systemic side effects. Bronchodilators should not be used as monotherapy because they do not address the underlying airway inflammation. They are most effective when combined with corticosteroid therapy. The Merck Veterinary Manual includes information on bronchodilator use in cats (Merck Veterinary Manual, https://www.merckvetmanual.com/). A review of feline asthma diagnosis and treatment from 2000 remains relevant for understanding bronchodilator indications (Feline asthma. Diagnosis and treatment, https://pubmed.ncbi.nlm.nih.gov/11221982).

Inhaler Therapy

Inhaler therapy delivers medication directly to the airways, maximizing local effect and minimizing systemic absorption. A metered-dose inhaler is attached to a spacer device with a face mask designed for cats. The cat is held gently, and the mask is placed over the nose and mouth. The inhaler is actuated, and the cat is allowed to take 7 to 10 breaths. Training the cat and owner is essential for successful administration. Inhaled corticosteroids are used for maintenance therapy, while inhaled bronchodilators are used as needed for acute signs. An update on feline asthma management highlights the benefits of inhaler therapy (Update on feline asthma, https://pubmed.ncbi.nlm.nih.gov/24268335). A study evaluating long-term therapy in cats with feline asthma and chronic bronchitis provides evidence on the efficacy of inhaled corticosteroids (Evaluation of long-term therapy in cats with feline asthma and chronic bronchitis, https://doi.org/10.1055/a-2031-2731).

Acute Exacerbation Management

Acute asthma exacerbations present as respiratory distress with tachypnea, open-mouth breathing, and cyanosis. Immediate intervention is required. Administer oxygen supplementation via flow-by or an oxygen cage. Inhaled albuterol can provide rapid bronchodilation. If the cat is unable to cooperate with inhaler therapy, injectable bronchodilators such as terbutaline may be used. Systemic corticosteroids (e.g., dexamethasone) are indicated for severe inflammation. Sedation with low-dose butorphanol may reduce stress and respiratory effort. Cats that do not respond to initial therapy require hospitalization for intensive monitoring and supportive care. Anaphylaxis in dogs and cats is a differential diagnosis for acute respiratory distress and should be considered in cats with sudden onset of signs following exposure to allergens (Anaphylaxis in dogs and cats, https://pubmed.ncbi.nlm.nih.gov/23855441).

Environmental Control

Environmental modification reduces exposure to inhaled allergens and irritants, decreasing the frequency and severity of asthma attacks. Identify and eliminate potential triggers in the cat's environment. Common triggers include cigarette smoke, aerosolized household cleaners, perfumes, scented candles, dusty cat litter, and mold. Use unscented, low-dust cat litter. Maintain good ventilation and consider using air purifiers with HEPA filters. Avoid the use of aerosolized flea control products. Keep the cat indoors to reduce exposure to outdoor allergens such as pollen and mold. A review of innovative management methods for patients allergic to cats discusses environmental control strategies relevant to feline asthma (Innovative management methods for patients allergic to cats, https://doi.org/10.15690/VSP.V19I4.2136). The World Organisation for Animal Health emphasizes the importance of environmental enrichment and stress reduction in managing chronic disease (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare).

Monitoring and Follow-Up

Regular monitoring is essential to assess treatment efficacy and adjust therapy as needed. Schedule recheck examinations every 1 to 3 months initially, then every 6 to 12 months once the condition is stable. At each visit, obtain a history of cough frequency, respiratory effort, and any adverse effects of medication. Perform a physical examination with emphasis on respiratory rate and auscultation. Repeat thoracic radiography if clinical signs worsen or if complications are suspected. Owners should maintain a daily log of cough episodes, medication administration, and any observed triggers. This log aids in identifying patterns and guiding management decisions. A study on chronic lower airway disease in dogs and cats provides a framework for long-term monitoring (Chronic lower airway disease in the dog and cat, https://api.elsevier.com/content/abstract/scopus_id/0026874218). Chronic lung disease in old dogs and cats also offers insights applicable to feline asthma management (Chronic lung disease in old dogs and cats, https://api.elsevier.com/content/abstract/scopus_id/0025297950).

Common Failure Patterns

Several factors can lead to suboptimal outcomes in feline asthma management. Inadequate corticosteroid dosing is a common cause of persistent clinical signs. Owners may underdose or skip doses due to concerns about side effects or difficulty administering medication. Poor inhaler technique reduces drug delivery to the airways. Ensure that owners are trained in proper spacer and mask use. Failure to identify and eliminate environmental triggers can result in ongoing allergen exposure and recurrent exacerbations. Concurrent conditions such as heartworm disease, lungworm infection, or chronic bronchitis may complicate diagnosis and treatment. Lack of response to therapy warrants reevaluation of the diagnosis and consideration of alternative or additional diseases. The Merck Veterinary Manual provides guidance on troubleshooting treatment failures (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Welfare and Safety Context

Feline asthma is a chronic condition that requires lifelong management. Untreated or poorly controlled asthma leads to progressive airway remodeling, reduced quality of life, and increased risk of fatal respiratory failure. Acute asthma attacks are distressing for the cat and the owner. Prompt recognition and treatment of exacerbations are critical. Corticosteroid therapy, particularly long-term oral administration, carries risks of diabetes mellitus, urinary tract infections, and skin thinning. Inhaled corticosteroids minimize these risks but require owner compliance and proper technique. Bronchodilators can cause tachycardia and tremors if overdosed. The World Organisation for Animal Health emphasizes the importance of balancing treatment benefits with potential adverse effects (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). The American College of Veterinary Internal Medicine provides resources on evidence-based treatment decisions (American College of Veterinary Internal Medicine, https://www.acvim.org/).

Professional Escalation Criteria

Referral to a veterinary internal medicine specialist is indicated in several scenarios. Cats with severe or refractory asthma that does not respond to standard therapy should be evaluated for alternative diagnoses or advanced treatment options. Cats requiring frequent or high-dose systemic corticosteroids may benefit from specialist guidance on steroid-sparing therapies. Cats with suspected complications such as pneumothorax, pulmonary hypertension, or cor pulmonale require advanced diagnostic imaging and management. Cats with concurrent diseases such as heartworm infection, lungworm infection, or chronic bronchitis may need specialized diagnostic testing and treatment. The International Society of Feline Medicine provides guidelines on when to refer (International Society of Feline Medicine, https://catvets.com/guidelines). A review of feline asthma treatment recommendations discusses advanced therapeutic options (Feline Asthma-Update on Diagnosis and Treatment Recommendations, https://pubmed.ncbi.nlm.nih.gov/42320919).

Practical Decision Framework for Adjusting Feline Asthma Therapy

Managing feline asthma requires a systematic approach to therapy adjustment based on objective clinical assessment instead of subjective owner impression alone. Without a structured decision framework, therapy changes often occur reactively during acute exacerbations instead of proactively to maintain disease control. This section provides a practical, evidence-informed framework for adjusting corticosteroid and bronchodilator therapy based on clinical response, adverse effects, and disease progression. The framework integrates findings from published reviews on feline asthma diagnosis and treatment (Feline Asthma: Diagnostic and Treatment Update, https://pubmed.ncbi.nlm.nih.gov/31812220) and long-term therapy evaluation (Evaluation of long-term therapy in cats with feline asthma and chronic bronchitis, https://doi.org/10.1055/a-2031-2731).

Step 1: Establish Baseline Disease Severity

Before initiating or adjusting therapy, classify the cat's disease severity using a standardized scoring system. This baseline allows objective measurement of treatment response. Use the following criteria adapted from clinical guidelines (International Society of Feline Medicine, https://catvets.com/guidelines):

Mild asthma: Cough less than once daily, no respiratory distress at rest, normal activity level, no emergency visits in the past 6 months. Thoracic radiographs show mild bronchial pattern or are normal. Bronchoalveolar lavage eosinophil percentage is 20-30%.

Moderate asthma: Cough one to three times daily, occasional wheezing audible without a stethoscope, mild tachypnea (respiratory rate 30-40 breaths per minute at rest), activity slightly reduced, one emergency visit in the past 6 months. Radiographs show moderate bronchial pattern with possible lung hyperinflation. BAL eosinophil percentage is 30-50%.

Severe asthma: Cough more than three times daily, frequent wheezing, tachypnea (respiratory rate greater than 40 breaths per minute at rest), open-mouth breathing episodes, reduced appetite or weight loss, two or more emergency visits in the past 6 months. Radiographs show marked bronchial pattern, lung hyperinflation, and possible right middle lobe collapse. BAL eosinophil percentage exceeds 50%.

Record the severity classification in the medical record along with the date and the scoring criteria used. This baseline guides initial therapy selection and provides a reference point for future adjustments.

Step 2: Select Initial Therapy Based on Severity

Use the severity classification to guide initial therapy selection. The Merck Veterinary Manual provides an overview of feline respiratory disease management (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Mild asthma: Begin with inhaled corticosteroid monotherapy. Fluticasone propionate 110 mcg per actuation, one puff twice daily via a spacer device with a face mask. No routine bronchodilator therapy. Instruct the owner to use the inhaled bronchodilator (albuterol 90 mcg per actuation, one puff as needed) only for cough episodes that do not resolve within 5 minutes of rest.

Moderate asthma: Begin with inhaled corticosteroid therapy. Fluticasone propionate 220 mcg per actuation, one puff twice daily. Add inhaled albuterol 90 mcg per actuation, one puff 10-15 minutes before each corticosteroid dose for the first 2 weeks to improve airway access. After 2 weeks, use albuterol only as needed for cough or respiratory distress.

Severe asthma: Begin with a short course of oral prednisolone 1-2 mg/kg twice daily for 5-7 days to rapidly reduce airway inflammation. Simultaneously start inhaled fluticasone propionate 220 mcg per actuation, one puff twice daily. After 5-7 days, taper oral prednisolone by 50% every 3-5 days while continuing inhaled therapy. Use inhaled albuterol 90 mcg per actuation, one puff every 4-6 hours as needed for respiratory distress. Hospitalize cats with severe respiratory distress for oxygen therapy and injectable medications.

A review of feline asthma treatment recommendations discusses the rationale for stepwise therapy (Feline Asthma-Update on Diagnosis and Treatment Recommendations, https://pubmed.ncbi.nlm.nih.gov/42320919).

Step 3: Implement a Structured Reassessment Schedule

Schedule reassessment at defined intervals to evaluate treatment response objectively. Use the following timeline:

Week 2: Telephone follow-up with the owner. Ask about cough frequency, respiratory effort, appetite, activity level, and any adverse effects. Instruct the owner to count respiratory rate at rest for 1 minute daily for 3 days before the call. Record the average respiratory rate. If respiratory rate exceeds 40 breaths per minute at rest, schedule an in-person examination.

Week 4: In-person recheck examination. Perform a complete physical examination with emphasis on respiratory rate, respiratory effort, and auscultation. Repeat thoracic radiographs if the cat had moderate or severe asthma at baseline or if clinical signs have not improved. Obtain a bronchoalveolar lavage if the cat has not improved and the diagnosis is uncertain. Record the severity classification using the same criteria as baseline.

Month 3: In-person recheck examination. Repeat thoracic radiographs if the cat had severe asthma at baseline or if clinical signs have worsened. Consider tapering therapy if the cat has been well-controlled for 2 consecutive months.

Month 6 and every 6-12 months thereafter: In-person recheck examination. Repeat thoracic radiographs annually or if clinical signs change. Adjust therapy based on the reassessment.

The American College of Veterinary Internal Medicine provides resources on monitoring chronic respiratory disease (American College of Veterinary Internal Medicine, https://www.acvim.org/).

Step 4: Apply a Standardized Therapy Adjustment Algorithm

Use the following algorithm to adjust therapy based on reassessment findings. The algorithm assumes that the diagnosis of feline asthma has been confirmed and that environmental triggers have been addressed.

Scenario A: Well-controlled (no cough, normal respiratory rate less than 30 breaths per minute at rest, normal activity, no adverse effects)

Maintain current therapy. If the cat has been well-controlled for 3 consecutive months on inhaled corticosteroid therapy, consider tapering the dose. For fluticasone propionate 220 mcg twice daily, reduce to 220 mcg once daily. For fluticasone propionate 110 mcg twice daily, reduce to 110 mcg once daily. Monitor for 4 weeks after dose reduction. If cough recurs, return to the previous dose.

Scenario B: Partially controlled (cough less than once daily, respiratory rate 30-40 breaths per minute at rest, mild wheezing, no emergency visits)

Increase the inhaled corticosteroid dose. For cats on fluticasone propionate 110 mcg twice daily, increase to 220 mcg twice daily. For cats on fluticasone propionate 220 mcg once daily, increase to twice daily. Add inhaled albuterol 90 mcg per actuation, one puff as needed for cough episodes. Reassess in 4 weeks. If still partially controlled, consider adding a second daily dose of albuterol (one puff twice daily) for 2 weeks, then reassess.

Scenario C: Poorly controlled (cough one to three times daily, respiratory rate greater than 40 breaths per minute at rest, wheezing audible without stethoscope, one emergency visit in the past 6 months)

Increase the inhaled corticosteroid dose to the maximum recommended: fluticasone propionate 220 mcg twice daily. Add inhaled albuterol 90 mcg per actuation, one puff twice daily for 2 weeks, then as needed. If the cat is already on maximum inhaled therapy, add oral prednisolone 0.5-1 mg/kg once daily for 7-10 days, then taper over 2-3 weeks while continuing inhaled therapy. Reassess in 2 weeks. If still poorly controlled, consider referral to a veterinary internal medicine specialist.

Scenario D: Uncontrolled (cough more than three times daily, respiratory distress at rest, open-mouth breathing episodes, two or more emergency visits in the past 6 months)

Hospitalize the cat for intensive therapy. Administer oxygen supplementation, injectable bronchodilators (terbutaline 0.01 mg/kg subcutaneously or intramuscularly), and injectable corticosteroids (dexamethasone 0.1-0.2 mg/kg intravenously or intramuscularly). Once stabilized, transition to oral prednisolone 1-2 mg/kg twice daily and inhaled fluticasone propionate 220 mcg twice daily. Taper oral prednisolone over 2-4 weeks. Reassess in 2 weeks. If still uncontrolled, refer to a veterinary internal medicine specialist for advanced diagnostics and alternative therapies.

An overview of diagnostics and therapy for feline asthma and chronic bronchitis provides additional context on treatment escalation ([Feline asthma and chronic bronchitis - an overview of diagnostics and therapy], https://pubmed.ncbi.nlm.nih.gov/31212350).

Step 5: Document Therapy Adjustments Using a Standardized Record System

Maintain a structured record of all therapy adjustments to track response over time and identify patterns. Use the following template for each therapy change:

Date of adjustment: [Date] Reason for adjustment: [Well-controlled, partially controlled, poorly controlled, uncontrolled, adverse effect, other] Previous therapy: [Drug, dose, frequency, route] New therapy: [Drug, dose, frequency, route] Clinical findings at adjustment: [Respiratory rate, cough frequency, severity classification, radiograph findings, BAL results if available] Adverse effects noted: [None, polyuria/polydipsia, increased appetite, vomiting, diarrhea, other] Owner concerns: [Describe] Next reassessment date: [Date]

Store this record in the cat's medical file and provide a copy to the owner. The owner should also maintain a daily log of cough episodes, medication administration, and any observed triggers. This log aids in identifying patterns and guiding management decisions. A study on chronic lower airway disease in dogs and cats provides a framework for long-term monitoring (Chronic lower airway disease in the dog and cat, https://api.elsevier.com/content/abstract/scopus_id/0026874218).

Troubleshooting Common Therapy Adjustment Failures

Several factors can lead to suboptimal outcomes when adjusting therapy. Address these systematically.

Failure to achieve control despite appropriate dose increases: Re-evaluate the diagnosis. Consider alternative or concurrent conditions such as chronic bronchitis, heartworm disease, lungworm infection, pneumonia, neoplasia, or tracheal collapse. Repeat thoracic radiographs and bronchoalveolar lavage. Perform heartworm antigen and antibody testing. Fecal examination for lungworm larvae is indicated in cats with outdoor access. A study on tomographic evaluation of bronchial and pulmonary vascular relationships in cats infected with immature Dirofilaria immitis highlights the importance of advanced imaging in differentiating asthma from other conditions (Tomographic Evaluation of the Bronchial and Pulmonary Vascular Relationships in Cats Naturally Infected with Immature Dirofilaria immitis, https://doi.org/10.3390/ani15223320).

Recurrent acute exacerbations despite maintenance therapy: Evaluate environmental trigger control. Ask the owner about any new exposures such as cigarette smoke, aerosolized cleaners, perfumes, scented candles, dusty cat litter, or mold. Consider using air purifiers with HEPA filters. Keep the cat indoors to reduce exposure to outdoor allergens. A review of innovative management methods for patients allergic to cats discusses environmental control strategies (Innovative management methods for patients allergic to cats, https://doi.org/10.15690/VSP.V19I4.2136).

Poor owner compliance with therapy: Assess the owner's understanding of the disease and treatment plan. Demonstrate proper inhaler technique at each visit. Provide written instructions with diagrams. Address any concerns about medication side effects or cost. Consider switching to a different route of administration if the owner cannot manage inhaler therapy. For example, oral prednisolone may be easier for some owners to administer, but carries higher risk of systemic side effects.

Adverse effects from therapy: Monitor for polyuria, polydipsia, increased appetite, weight gain, vomiting, diarrhea, and behavioral changes. If adverse effects occur with oral corticosteroids, taper the dose and transition to inhaled corticosteroids. If adverse effects occur with inhaled corticosteroids, ensure proper technique to minimize oral deposition. Rinse the cat's mouth with water after each inhaled dose. If adverse effects persist, consider reducing the dose or switching to a different inhaled corticosteroid.

Lack of response to bronchodilator therapy: Ensure that the bronchodilator is being administered correctly. The spacer device must be properly attached to the inhaler, and the mask must form a good seal around the cat's nose and mouth. The cat should take 7-10 breaths after each actuation. If the cat is uncooperative, consider injectable bronchodilators for acute episodes. Do not use bronchodilators as monotherapy because they do not address the underlying airway inflammation.

An update on feline asthma management discusses troubleshooting common treatment failures (Update on feline asthma, https://pubmed.ncbi.nlm.nih.gov/24268335).

Records and Measurements for Therapy Adjustment

Maintain the following records to support therapy adjustment decisions:

Daily owner log: Cough episodes (time, duration, severity), respiratory rate at rest (once daily, measured when the cat is sleeping), medication administration (time, dose, any difficulty), observed triggers, appetite, activity level, and any adverse effects.

Monthly summary: Average daily cough frequency, average resting respiratory rate, number of rescue bronchodilator uses, number of emergency visits, and any changes in appetite or activity.

Recheck examination records: Date, body weight, respiratory rate, respiratory effort, auscultation findings, severity classification, thoracic radiograph findings (if performed), BAL results (if performed), and any adverse effects noted.

Therapy adjustment records: Date of adjustment, reason, previous therapy, new therapy, clinical findings, adverse effects, owner concerns, and next reassessment date.

These records allow objective assessment of disease control and guide therapy adjustments. Chronic lung disease in old dogs and cats offers insights applicable to long-term monitoring (Chronic lung disease in old dogs and cats, https://api.elsevier.com/content/abstract/scopus_id/0025297950).

Common Failure Patterns in Therapy Adjustment

Several patterns of failure occur frequently when adjusting feline asthma therapy. Recognizing these patterns allows early intervention.

Pattern 1: Inadequate dose escalation. Owners and veterinarians may be reluctant to increase corticosteroid doses due to concerns about side effects. This leads to persistent clinical signs and progressive airway remodeling. Follow the stepwise algorithm and increase doses as indicated until control is achieved.

Pattern 2: Premature dose reduction. Once the cat improves, owners may reduce the dose too quickly, leading to relapse. Taper doses gradually over weeks to months, and monitor closely for recurrence of clinical signs.

Pattern 3: Reliance on bronchodilators as monotherapy. Bronchodilators provide rapid symptom relief but do not address airway inflammation. Cats that receive bronchodilators without corticosteroids are at risk for progressive disease and acute exacerbations. Always combine bronchodilators with anti-inflammatory therapy.

Pattern 4: Failure to address environmental triggers. Even with optimal medical therapy, ongoing exposure to allergens can cause persistent clinical signs. Conduct a thorough environmental history at each recheck and make specific recommendations for trigger reduction.

Pattern 5: Misdiagnosis. Cats with chronic bronchitis, heartworm disease, lungworm infection, or other respiratory conditions may not respond to asthma therapy. If the cat does not improve with appropriate dose escalation, re-evaluate the diagnosis.

The Merck Veterinary Manual provides guidance on troubleshooting treatment failures (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Welfare and Safety Context for Therapy Adjustment

Therapy adjustment decisions must balance disease control with potential adverse effects. Corticosteroid therapy, particularly long-term oral administration, carries risks of diabetes mellitus, urinary tract infections, and skin thinning. Inhaled corticosteroids minimize these risks but require owner compliance and proper technique. Bronchodilators can cause tachycardia and tremors if overdosed. The World Organisation for Animal Health emphasizes the importance of balancing treatment benefits with potential adverse effects (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare).

Monitor for signs of corticosteroid overdose: polyuria, polydipsia, increased appetite, weight gain, panting, and behavioral changes. If these signs occur, taper the dose and transition to inhaled therapy. Monitor for signs of bronchodilator overdose: tachycardia, tremors, hyperactivity, and vomiting. If these signs occur, reduce the dose or frequency.

Acute asthma exacerbations are distressing for the cat and the owner. Prompt recognition and treatment of exacerbations are critical. Instruct owners to seek emergency care if the cat shows open-mouth breathing, rapid breathing, blue gums, or collapse. Anaphylaxis in dogs and cats is a differential diagnosis for acute respiratory distress and should be considered in cats with sudden onset of signs following exposure to allergens (Anaphylaxis in dogs and cats, https://pubmed.ncbi.nlm.nih.gov/23855441).

Professional Escalation Criteria for Therapy Adjustment

Referral to a veterinary internal medicine specialist is indicated in several scenarios related to therapy adjustment:

• Cats that remain poorly controlled or uncontrolled despite maximum inhaled corticosteroid therapy and appropriate dose escalation
• Cats that require frequent or high-dose systemic corticosteroids to maintain control
• Cats that develop significant adverse effects from therapy
• Cats with suspected complications such as pneumothorax, pulmonary hypertension, or cor pulmonale
• Cats with concurrent diseases such as heartworm infection, lungworm infection, or chronic bronchitis that complicate therapy
• Cats with suspected alternative diagnoses that have not been ruled out

The International Society of Feline Medicine provides guidelines on when to refer (International Society of Feline Medicine, https://catvets.com/guidelines). A review of feline asthma treatment recommendations discusses advanced therapeutic options available through specialist referral (Feline Asthma-Update on Diagnosis and Treatment Recommendations, https://pubmed.ncbi.nlm.nih.gov/42320919).

A study on clinical and histopathological investigation of tracheobronchial disease in cats with chronic gingivostomatitis suggests a possible link between oral inflammation and lower airway disease, warranting further investigation in cats with concurrent oral pathology (Clinical and histopathological investigation of the possible occurrence of tracheobronchial disease in cats with chronic gingivostomatitis, https://doi.org/10.3389/fvets.2025.1624016).

Frequently Asked Questions

What is the difference between feline asthma and chronic bronchitis?

Feline asthma is an allergic eosinophilic airway disease with reversible bronchoconstriction, while chronic bronchitis is a neutrophilic inflammatory condition with irreversible airway changes. Asthma typically responds well to corticosteroids, whereas chronic bronchitis may require additional therapies. Diagnosis is confirmed by bronchoalveolar lavage cytology. The Merck Veterinary Manual provides information on differentiating these conditions (Merck Veterinary Manual, https://www.merckvetmanual.com/).

How is feline asthma diagnosed?

Diagnosis is based on history, physical examination, thoracic radiography, and bronchoalveolar lavage cytology. Radiographs may show a bronchial pattern and lung hyperinflation. Bronchoalveolar lavage with greater than 20% eosinophils confirms eosinophilic airway disease. Ruling out other causes of respiratory signs such as heartworm disease, lungworm infection, and pneumonia is essential. The American College of Veterinary Internal Medicine offers resources on diagnostic approaches (American College of Veterinary Internal Medicine, https://www.acvim.org/).

What are the treatment options for feline asthma?

Treatment includes corticosteroids to reduce inflammation and bronchodilators to relieve bronchoconstriction. Inhaled corticosteroids are preferred for long-term management due to fewer systemic side effects. Inhaled bronchodilators are used as rescue therapy for acute attacks. Environmental control to reduce allergen exposure is also important. A review of feline asthma diagnosis and treatment discusses these options (Feline Asthma: Diagnostic and Treatment Update, https://pubmed.ncbi.nlm.nih.gov/31812220).

Can feline asthma be cured?

Feline asthma is a chronic condition that cannot be cured but can be managed effectively with appropriate therapy and environmental control. Lifelong treatment is typically required to control clinical signs and prevent airway remodeling. Regular monitoring and adjustment of therapy are necessary to maintain quality of life. The World Organisation for Animal Health addresses chronic disease management (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare).

What are the side effects of corticosteroid therapy in cats?

Oral corticosteroids can cause increased thirst and urination, increased appetite, weight gain, and behavioral changes. Long-term use increases the risk of diabetes mellitus, urinary tract infections, and skin thinning. Inhaled corticosteroids minimize systemic side effects but can cause oral or pharyngeal irritation. Proper inhaler technique and rinsing the cat's mouth after administration can reduce local side effects. An update on feline asthma management discusses these risks (Update on feline asthma, https://pubmed.ncbi.nlm.nih.gov/24268335).

How do I administer inhaled medication to my cat?

Attach the metered-dose inhaler to a spacer device with a face mask designed for cats. Gently hold the cat and place the mask over the nose and mouth. Actuate the inhaler and allow the cat to take 7 to 10 breaths. Training and patience are essential for success. Positive reinforcement with treats can help the cat accept the procedure. A review of feline asthma treatment recommendations provides guidance on inhaler use (Feline Asthma-Update on Diagnosis and Treatment Recommendations, https://pubmed.ncbi.nlm.nih.gov/42320919).

What environmental changes can help my cat with asthma?

Identify and eliminate potential triggers such as cigarette smoke, aerosolized cleaners, perfumes, scented candles, and dusty cat litter. Use unscented, low-dust litter. Maintain good ventilation and consider using HEPA air purifiers. Keep the cat indoors to reduce exposure to outdoor allergens. A review of innovative management methods for patients allergic to cats discusses environmental control (Innovative management methods for patients allergic to cats, https://doi.org/10.15690/VSP.V19I4.2136).

When should I seek emergency veterinary care for my cat with asthma?

Seek emergency care if your cat shows signs of respiratory distress such as open-mouth breathing, rapid breathing, blue gums, or collapse. Acute asthma attacks require immediate intervention with oxygen and bronchodilators. Cats that do not respond to rescue medication at home should be evaluated by a veterinarian. Anaphylaxis in dogs and cats is a differential diagnosis for acute respiratory distress (Anaphylaxis in dogs and cats, https://pubmed.ncbi.nlm.nih.gov/23855441).

Related Veterinary Guides

• Cat
• Hypertrophic Cardiomyopathy In Cats
• Prescription Medicine For Cats
• Sneezing Cat Remedy
• Cat Tapeworm Medicine

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Feline Asthma: Diagnostic and Treatment Update.. The Veterinary clinics of North America. Small animal practice, 2020.
• [Feline asthma and chronic bronchitis - an overview of diagnostics and therapy].. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 2019.
• Feline Asthma-Update on Diagnosis and Treatment Recommendations.. The Veterinary clinics of North America. Small animal practice, 2026.
• Feline asthma. Diagnosis and treatment.. The Veterinary clinics of North America. Small animal practice, 2000.
• Anaphylaxis in dogs and cats.. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2013.
• Update on feline asthma.. The Veterinary clinics of North America. Small animal practice, 2014.
• Chronic lung disease in old dogs and cats. Veterinary Record, 1990.
• Tomographic Evaluation of the Bronchial and Pulmonary Vascular Relationships in Cats Naturally Infected with Immature Dirofilaria immitis. Animals, 2025.
• Clinical and histopathological investigation of the possible occurrence of tracheobronchial disease in cats with chronic gingivostomatitis. Frontiers in Veterinary Science, 2025.
• Innovative management methods for patients allergic to cats. Voprosy Sovremennoi Pediatrii Current Pediatrics, 2020.
• Evaluation of long-term therapy in cats with feline asthma and chronic bronchitis. Tierarztliche Praxis Ausgabe K Kleintiere Heimtiere, 2022.
• Chronic lower airway disease in the dog and cat.. Problems in Veterinary Medicine, 1992.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.